Page last updated: 2024-11-05

troglitazone and Diathesis

troglitazone has been researched along with Diathesis in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, M1
Saekusa, Y1
Dewa, Y1
Nishimura, J1
Matsumoto, S1
Shibutani, M1
Hasumi, K1
Mitsumori, K1

Other Studies

1 other study available for troglitazone and Diathesis

ArticleYear
Hepatocarcinogenic susceptibility of rasH2 mice to troglitazone in a two-stage hepatocarcinogenesis model.
    Archives of toxicology, 2009, Volume: 83, Issue:2

    Topics: Animals; Biomarkers, Tumor; Body Weight; Carcinogens; Chromans; Disease Models, Animal; Disease Susc

2009